I was a former provincial deputy minister and this is not an area wherein the provinces, although we do look to them on many other fronts, would necessarily have that kind of expertise, although they may in some regulatory areas. We certainly would look to them in many cases, but here I think it's the other international regulators. The USFDA is obviously a very well-known, well-respected institution and there's the European Medicines Agency. We have partnership agreements with a number of regulatory bodies in Australia, the U.K., and others, so that we can actually take from those who are dealing with a very similar set of challenges.
As Paul mentioned, we in fact have an ongoing regulatory dialogue with those other parties because this is a very complex and rapidly evolving world, and we want to make sure that we're learning from other regulators across the spectrum, including in this area.